All In Biotech

Drug Trial Radar · NCT06619860

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of Oral VX-993 in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Last checked: Nov 19, 2026Latest source record: Jun 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Oct 18, 2024

Primary completion

Mar 25, 2027

Study completion Apr 22, 2027

Sponsor

Lead sponsor
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
Sponsor type
Industry
First posted
Oct 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)

Conditions

  • Diabetic Peripheral Neuropathic Pain

Interventions

  • VX-993Drug

    Tablets for oral administration.

  • PregabalinDrug

    Capsules for oral administration.

  • Placebo (matched to pregabalin)Drug

    Placebo matched to pregabalin for oral administration.

  • Placebo (matched to VX-993)Drug

    Placebo matched to VX-993 for oral administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Weekly Average of Daily Pain Intensity on the Numeric Pain Rating Scale (NPRS) at Week 12Time frame: From Baseline up to Week 12

Locations

47 sites in 6 countries. Site status is shown where the registry gives one.

  • Cullman Clinical Trials

    Cullman, Alabama · Completed

  • Trovare Clinical Research - Bakersfield CA

    Bakersfield, California · Completed

  • Eximia Research - San Diego

    La Mesa, California · Completed

  • Paradigm Clincial Research Centers, LLC., Wheat Ridge

    Wheat Ridge, Colorado · Completed

  • Accel Research - Deland

    DeLand, Florida · Completed

  • AMR Fort Myers (The Clinical Study Center)

    Fort Myers, Florida · Completed

  • Velocity Clinical Research - Hallandale Beach

    Hallandale, Florida · Completed

  • Health Awareness, Inc., Jupiter

    Jupiter, Florida · Completed

  • Suncoast Research Associates - Miami

    Miami, Florida · Completed

  • Innovation Medical Research Center - Palmetto

    Palmetto Bay, Florida · Completed

  • Health Awareness, Inc. - Port St. Lucie

    Port Saint Lucie, Florida · Completed

  • Atlanta Center for Medical Research

    Atlanta, Georgia · Completed

  • Accel Research - Decatur

    Decatur, Georgia · Completed

  • Velocity Clinical Research - Boise

    Meridian, Idaho · Completed

  • Healthcare Research Network - Flossmoor IL

    Flossmoor, Illinois · Completed

  • Quest Research Institute

    Farmington Hills, Michigan · Completed

  • Healthcare Research Network - Hazelwood MO

    Hazelwood, Missouri · Completed

  • Eximia Research - Raleigh

    Raleigh, North Carolina · Completed

  • Velocity Clinical Research - Cleveland

    Beachwood, Ohio · Completed

  • Velocity Clinical Research - Providence

    East Greenwich, Rhode Island · Completed

  • Clinical Trials of South Carolina - Berkeley - Moncks Corner

    Moncks Corner, South Carolina · Completed

  • Gadolin Research

    Beaumont, Texas · Completed

  • Velocity Clinical Research, Dallas

    Dallas, Texas · Completed

  • San Antonio Clinical Trials

    San Antonio, Texas · Completed

  • AMR Norfolk

    Norfolk, Virginia · Completed

  • Centricity Research Brampton

    Brampton, Canada · Recruiting

  • OCT Research ULC

    Kelowna, Canada · Recruiting

  • Altasciences - Beaumont Clinic Montreal

    Montreal, Canada · Recruiting

  • Mount Sinai Hospital - Leadership Sinai Centre for Diabetes (LSCD)

    Toronto, Canada · Recruiting

  • Centre Hospitalier Universitaire de Clermont-Ferrand - Site Gabriel-Montpied

    Clermont-Ferrand, France · Recruiting

  • CHU de Nîmes - Pain Assessment and Treatment Center

    Nîmes, France · Recruiting

  • Hopital Cochin - Rheumatology

    Paris, France · Recruiting

  • North Hospital

    Saint-Priest-en-Jarez, France · Recruiting

  • Ruhr-Universitaet Bochum - Heart and Diabetes Center

    Bad Oeynhausen, Germany · Recruiting

  • FutureMeds GmbH

    Berlin, Germany · Recruiting

  • FutureMeds Frankfurt

    Offenbach/Main, Germany · Recruiting

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    Milan, Italy · Recruiting

  • IRCCS Ospedale San Raffaele - InSpe and Division of Neuroscience

    Milan, Italy · Recruiting

  • Birmingham Heartlands Hospital - Heartlands Hospital Diabetes Centre and MIDRU

    Birmingham, United Kingdom · Recruiting

  • FutureMeds Birmingham

    Birmingham, United Kingdom · Recruiting

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.